American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

CVS HEALTH CORPORATION

CVS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

CVS historical prices

$CVS stock is featured in our Sheldon Whitehouse, Shelley Moore Capito, and Top Lobbying Spenders strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of CVS by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Sale $1,001 - $15,000 Aug 24, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 02, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 May 15, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 May 01, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 13, 2026
Alan Armstrong Senate / R Purchase $1,001 - $15,000 Mar 27, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Feb 24, 2026
Michael T. McCaul House / R Purchase $15,001 - $50,000 Feb 20, 2026
John Boozman Senate / R Purchase $1,001 - $15,000 Jan 29, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Jan 29, 2026
Michael T. McCaul House / R Sale $15,001 - $50,000 Jan 13, 2026
Dwight Evans House / D Sale $1,001 - $15,000 Nov 21, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 31, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Oct 30, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 30, 2025
Michael T. McCaul House / R Sale $15,001 - $50,000 Oct 27, 2025
Val T. Hoyle House / D Sale $1,001 - $15,000 Sep 23, 2025
Michael T. McCaul House / R Sale $50,001 - $100,000 Aug 22, 2025
Michael T. McCaul House / R Sale $50,001 - $100,000 Aug 22, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Michael T. McCaul House / R Sale $100,001 - $250,000 Jun 27, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 28, 2025
Ro Khanna House / D Sale $1,001 - $15,000 May 19, 2025
Robert Bresnahan House / R Sale $1,001 - $15,000 May 15, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 May 12, 2025
Michael T. McCaul House / R Sale $100,001 - $250,000 Apr 10, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Apr 01, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 12, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 06, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 Feb 25, 2025
J. French Hill House / R Sale $15,001 - $50,000 Jan 31, 2025
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Jan 24, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 22, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Jan 15, 2025
Michael T. McCaul House / R Purchase $100,001 - $250,000 Jan 13, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Nov 15, 2024
Val T. Hoyle House / D Purchase $1,001 - $15,000 Oct 29, 2024
Thomas R. Suozzi House / D Sale $1,001 - $15,000 Oct 24, 2024
Ro Khanna House / D Sale $15,001 - $50,000 N/A
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Aug 26, 2024
Michael T. McCaul House / R Purchase $15,001 - $50,000 Aug 12, 2024
Michael T. McCaul House / R Purchase $100,001 - $250,000 Aug 12, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Sale $15,001 - $50,000 Aug 02, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 02, 2024
Earl Blumenauer House / D Sale $1,001 - $15,000 Jun 27, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 07, 2024
Michael T. McCaul House / R Purchase $1,001 - $15,000 Jun 05, 2024
CVS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CVS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CVS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in CVS holdings by institutional investors

Insider Trading

Quarterly net insider trading by CVS's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $3,570,000 Jul 20, 2026 Issue: Pharmacy Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Consumer Issues/Safety/Products Advertising Medicare/Medicaid Insurance
  • $3,320,000 Apr 20, 2026 Issue: Consumer Issues/Safety/Products Advertising Pharmacy Taxation/Internal Revenue Code Medicare/Medicaid Insurance Labor Issues/Antitrust/Workplace
  • $2,270,000 Jan 20, 2026 Issue: Pharmacy Taxation/Internal Revenue Code Medicare/Medicaid Insurance Labor Issues/Antitrust/Workplace Consumer Issues/Safety/Products Advertising
  • $2,150,000 Oct 20, 2025 Issue: Pharmacy Taxation/Internal Revenue Code Medicare/Medicaid Insurance Labor Issues/Antitrust/Workplace Consumer Issues/Safety/Products Advertising
  • $1,810,000 Jul 21, 2025 Issue: Pharmacy Taxation/Internal Revenue Code Medicare/Medicaid Insurance Labor Issues/Antitrust/Workplace Consumer Issues/Safety/Products Advertising
  • $3,460,000 Apr 21, 2025 Issue: Pharmacy Taxation/Internal Revenue Code Medicare/Medicaid Insurance Labor Issues/Antitrust/Workplace Consumer Issues/Safety/Products
  • $2,040,000 Jan 21, 2025 Issue: Pharmacy Taxation/Internal Revenue Code Medicare/Medicaid Insurance Labor Issues/Antitrust/Workplace Consumer Issues/Safety/Products
  • $1,520,000 Oct 21, 2024 Issue: Consumer Issues/Safety/Products Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $2,470,000 Jul 23, 2024 Issue: Consumer Issues/Safety/Products Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $1,770,000 Jan 22, 2024 Issue: Consumer Issues/Safety/Products Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $1,460,000 Oct 20, 2023 Issue: Consumer Issues/Safety/Products Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $1,500,000 Jul 20, 2023 Issue: Consumer Issues/Safety/Products Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $3,790,000 Jan 20, 2023 Issue: Consumer Issues/Safety/Products Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $1,620,000 Oct 21, 2022 Issue: Consumer Issues/Safety/Products Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $1,470,000 Jul 20, 2022 Issue: Consumer Issues/Safety/Products Postal Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $3,670,000 Apr 20, 2022 Issue: Consumer Issues/Safety/Products Postal Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $2,550,000 Jan 20, 2022 Issue: None
  • $2,280,000 Oct 20, 2021 Issue: None
  • $2,540,000 Jul 20, 2021 Issue: None
  • $2,300,000 Apr 20, 2021 Issue: None
  • $2,300,000 Jan 21, 2021 Issue: None
  • $2,260,000 Oct 20, 2020 Issue: None
  • $2,120,000 Jul 20, 2020 Issue: None
  • $3,460,000 Apr 20, 2020 Issue: None
  • $2,262,000 Jan 21, 2020 Issue: None
  • $2,625,000 Oct 21, 2019 Issue: Pharmacy Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Health Issues Veterans
  • $2,200,000 Jul 22, 2019 Issue: Pharmacy Insurance Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Health Issues
  • $2,400,000 Apr 22, 2019 Issue: Pharmacy Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Insurance
  • $1,993,000 Jan 22, 2019 Issue: Pharmacy Labor Issues/Antitrust/Workplace Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Health Issues Veterans
  • $1,442,000 Oct 22, 2018 Issue: Pharmacy Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Veterans
  • $1,300,000 Jul 20, 2018 Issue: Pharmacy Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Veterans
  • $1,803,000 Apr 20, 2018 Issue: Pharmacy Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Veterans
  • $1,680,000 Jan 22, 2018 Issue: Pharmacy Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Veterans Health Issues Labor Issues/Antitrust/Workplace
  • $1,450,000 Oct 20, 2017 Issue: Pharmacy Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Communications/Broadcasting/Radio/TV Veterans
  • $1,512,000 Jul 20, 2017 Issue: Communications/Broadcasting/Radio/TV Pharmacy Labor Issues/Antitrust/Workplace Medicare/Medicaid Taxation/Internal Revenue Code Health Issues Veterans
  • $1,770,000 Apr 20, 2017 Issue: Medicare/Medicaid Health Issues Veterans Labor Issues/Antitrust/Workplace Pharmacy Taxation/Internal Revenue Code
  • $2,080,000 Jan 23, 2017 Issue: Pharmacy Medicare/Medicaid Taxation/Internal Revenue Code Health Issues Veterans Food Industry (safety, labeling, etc.) Copyright/Patent/Trademark
  • $1,320,000 Oct 20, 2016 Issue: Pharmacy Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Veterans
  • $1,158,247 Jul 20, 2016 Issue: Pharmacy Veterans Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $1,460,000 Apr 20, 2016 Issue: Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $4,210,000 Jan 20, 2016 Issue: Pharmacy Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues Postal Taxation/Internal Revenue Code
  • $3,250,000 Oct 20, 2015 Issue: Pharmacy Medicare/Medicaid Postal Health Issues Labor Issues/Antitrust/Workplace Trucking/Shipping Taxation/Internal Revenue Code
  • $3,700,000 Jul 21, 2015 Issue: Pharmacy Medicare/Medicaid Health Issues Postal Taxation/Internal Revenue Code Trucking/Shipping
  • $4,070,000 Apr 20, 2015 Issue: Pharmacy Medicare/Medicaid Postal Health Issues Taxation/Internal Revenue Code Trucking/Shipping
  • $3,810,000 Jan 21, 2015 Issue: Pharmacy Medicare/Medicaid Trucking/Shipping Health Issues Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Postal
  • $40,000 Nov 07, 2014 Issue: Health Issues Postal Labor Issues/Antitrust/Workplace Pharmacy Taxation/Internal Revenue Code
  • $30,000 Oct 22, 2014 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Medicare/Medicaid
  • $60,000 Oct 20, 2014 Issue: Pharmacy Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $30,000 Jul 21, 2014 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Postal Pharmacy
  • $60,000 Jul 21, 2014 Issue: Labor Issues/Antitrust/Workplace Health Issues Medicare/Medicaid Pharmacy Taxation/Internal Revenue Code
  • $40,000 Jul 09, 2014 Issue: Labor Issues/Antitrust/Workplace Postal Health Issues Pharmacy Accounting Taxation/Internal Revenue Code
  • $30,000 Apr 21, 2014 Issue: Pharmacy Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Postal
  • $60,000 Apr 21, 2014 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues Pharmacy Taxation/Internal Revenue Code
  • $40,000 Apr 03, 2014 Issue: Taxation/Internal Revenue Code Health Issues Postal Labor Issues/Antitrust/Workplace Pharmacy
  • $60,000 Jan 17, 2014 Issue: Pharmacy Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $30,000 Jan 15, 2014 Issue: Pharmacy Taxation/Internal Revenue Code Postal Health Issues Medicare/Medicaid Labor Issues/Antitrust/Workplace
  • $40,000 Jan 08, 2014 Issue: Health Issues Labor Issues/Antitrust/Workplace Pharmacy Taxation/Internal Revenue Code Postal
  • $60,000 Oct 21, 2013 Issue: Labor Issues/Antitrust/Workplace Postal Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Pharmacy
  • $60,000 Oct 21, 2013 Issue: Health Issues Labor Issues/Antitrust/Workplace Pharmacy Taxation/Internal Revenue Code Postal Medicare/Medicaid
  • $40,000 Oct 02, 2013 Issue: Labor Issues/Antitrust/Workplace Health Issues Taxation/Internal Revenue Code Postal Pharmacy
  • $60,000 Jul 22, 2013 Issue: Pharmacy Postal Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Labor Issues/Antitrust/Workplace
  • $60,000 Jul 22, 2013 Issue: Pharmacy Health Issues Labor Issues/Antitrust/Workplace Postal Medicare/Medicaid Taxation/Internal Revenue Code
  • $40,000 Jul 15, 2013 Issue: Pharmacy Labor Issues/Antitrust/Workplace Taxation/Internal Revenue Code Health Issues Postal
  • $60,000 Apr 22, 2013 Issue: Medicare/Medicaid Postal Health Issues Labor Issues/Antitrust/Workplace Pharmacy Taxation/Internal Revenue Code
  • $60,000 Apr 19, 2013 Issue: Medicare/Medicaid Health Issues Postal Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Pharmacy
  • $40,000 Apr 18, 2013 Issue: Postal Labor Issues/Antitrust/Workplace Taxation/Internal Revenue Code Health Issues Pharmacy
  • $60,000 Jan 22, 2013 Issue: Government Issues Medicare/Medicaid Health Issues Consumer Issues/Safety/Products Labor Issues/Antitrust/Workplace Defense Taxation/Internal Revenue Code
  • $60,000 Jan 11, 2013 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Labor Issues/Antitrust/Workplace
  • $60,000 Oct 22, 2012 Issue: Medicare/Medicaid Government Issues Defense Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Health Issues Consumer Issues/Safety/Products
  • $40,000 Oct 19, 2012 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Labor Issues/Antitrust/Workplace Pharmacy
  • $60,000 Jul 20, 2012 Issue: Labor Issues/Antitrust/Workplace Government Issues Consumer Issues/Safety/Products Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $60,000 Apr 20, 2012 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Taxation/Internal Revenue Code Health Issues Government Issues Labor Issues/Antitrust/Workplace
  • $60,000 Jan 20, 2012 Issue: Labor Issues/Antitrust/Workplace Health Issues Taxation/Internal Revenue Code Consumer Issues/Safety/Products Government Issues
  • $60,000 Oct 20, 2011 Issue: Consumer Issues/Safety/Products Government Issues Financial Institutions/Investments/Securities Labor Issues/Antitrust/Workplace Taxation/Internal Revenue Code Health Issues
  • $60,000 Jul 20, 2011 Issue: Government Issues Health Issues Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Financial Institutions/Investments/Securities Consumer Issues/Safety/Products
  • $140,000 Apr 20, 2011 Issue: Insurance Taxation/Internal Revenue Code Health Issues Financial Institutions/Investments/Securities
  • $60,000 Jan 20, 2011 Issue: Labor Issues/Antitrust/Workplace Health Issues
  • $60,000 Oct 20, 2010 Issue: Health Issues Labor Issues/Antitrust/Workplace
  • $60,000 Jul 20, 2010 Issue: Labor Issues/Antitrust/Workplace Health Issues Government Issues
  • $60,000 Apr 20, 2010 Issue: Health Issues Medicare/Medicaid Government Issues Labor Issues/Antitrust/Workplace
  • $60,000 Jan 20, 2010 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues
  • $60,000 Oct 20, 2009 Issue: Labor Issues/Antitrust/Workplace Health Issues Medicare/Medicaid
  • $60,000 Jul 20, 2009 Issue: Medicare/Medicaid Health Issues Labor Issues/Antitrust/Workplace Science/Technology
  • $60,000 Apr 20, 2009 Issue: Labor Issues/Antitrust/Workplace Science/Technology Health Issues Medicare/Medicaid
  • $50,000 Jan 21, 2009 Issue: Science/Technology Medicare/Medicaid Health Issues Labor Issues/Antitrust/Workplace
  • $50,000 Oct 17, 2008 Issue: Pharmacy Medicare/Medicaid Science/Technology Labor Issues/Antitrust/Workplace Health Issues
  • $50,000 Jul 21, 2008 Issue: Medicare/Medicaid Health Issues Labor Issues/Antitrust/Workplace
  • $50,000 Apr 21, 2008 Issue: Medicare/Medicaid Health Issues Labor Issues/Antitrust/Workplace
  • $100,000 Feb 08, 2008 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues
  • $100,000 Aug 14, 2007 Issue: Medicare/Medicaid Health Issues Labor Issues/Antitrust/Workplace
  • $100,000 Feb 13, 2007 Issue: Medicare/Medicaid Health Issues
  • $60,000 Aug 04, 2004 Issue: District of Columbia Medical/Disease Research/Clinical Labs Health Issues
Revolving Door

Former government officials who have lobbied for CVS

99 former government officials from 58 congressional offices at 19 lobbying firms have lobbied for CVS, most recently Jul 20, 2026.

  • Debbie Wasserman Schultz
    Daniel Farmer House Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space Formerly with Debbie Wasserman Schultz · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Bill Cassidy
    Robb Walton Senate Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes Formerly with Bill Cassidy · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Scott L. Klug
    Robert Wood House Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug Formerly with Scott L. Klug · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Ron Wyden
    Raghav Aggarwal Senate Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior Formerly with Ron Wyden · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Marsha Blackburn
    Chris Kelly Senate Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn Formerly with Marsha Blackburn · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Markwayne Mullin
    Adam Buckalew House Covered Official Positions Continued: Deputy Chief of Staff, U.S. Rep. Markwayne Mullin (R-OK); Communications Director & Legislative Assistant, U.S. Rep. Gregg Harper (R-MS) Formerly with Markwayne Mullin · ALB SOLUTIONS · Jul 16, 2026
  • Veronica Jackson Executive Director, Strategic Planning, Office of the Assistant Secretary for Public Affairs, HHS Formerly Director, Strategic Planning, Office of the Assistant Secretary for Public Affairs, HHS · ALB SOLUTIONS · Jul 16, 2026
  • Timothy Costa Congress Former Chief of Staff to Dan Meuser Formerly Former Chief of Staff to Dan Meuser · CONTINENTAL STRATEGY, LLC · Apr 17, 2026
See all 99 on the Revolving Door dashboard
Corporate Lobbying

CVS Estimated quarterly lobbying spending

Revenue Breakdown

CVS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CVS Income Statement
CVS Balance Sheet
CVS Cash Flow
U.S. Patents

New CVS patent grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to CVS from public contracts

CVS News

Recent insights relating to CVS

CNBC Recommendations

Recent picks made for CVS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CVS

CVS Analyst Ratings

CVS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CVS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CVS stock a Buy, Sell, or Hold?

  • What is the price target for $CVS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CVS Top Shareholders
Shareholder
Shares Held
CVS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CVS stock?

  • Who owns the most shares of $CVS stock?

  • What funds own $CVS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CVS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CVS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CVS

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 26 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.

  • Address Woonsocket, RI
  • Market Cap 111.4 billion
  • Employees 300,000
  • Industrial Classification Retail-Drug Stores And Proprietary Stores

CVS HEALTH CORPORATION (CVS) Historical Stock Prices

CVS HEALTH CORPORATION (CVS) closed at $87.10 on September 22, 2026. Over the past year its adjusted close ranged from $69.06 to $109.92. Daily prices go back to January 2, 2014, 3,199 trading days in all.

  • 1 month-6.36%
  • 3 months-13.71%
  • Year to date+12.26%
  • 1 year+19.56%
  • 3 years+37.17%
  • 5 years+21.07%
  • Max+75.44%
See every congressional and insider trade on the CVS price chart

Quiver Premium charts CVS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 87.69 88.28 86.68 87.10 87.10 8,712,158
Sep 21, 2026 88.73 88.91 87.19 87.60 87.60 10,137,932
Sep 18, 2026 90.09 90.48 88.15 88.84 88.84 21,880,291
Sep 17, 2026 92.00 92.14 90.17 90.27 90.27 7,434,654
Sep 16, 2026 94.46 94.95 91.44 91.72 91.72 7,235,058
Sep 15, 2026 95.74 95.75 93.84 94.49 94.49 5,002,424
Sep 14, 2026 95.44 96.01 95.28 95.55 95.55 4,453,640
Sep 11, 2026 95.78 96.41 93.91 94.66 94.66 4,380,268
Sep 10, 2026 96.01 97.32 94.88 95.29 95.29 3,877,979
Sep 9, 2026 97.39 97.98 92.79 95.38 95.38 6,112,458
Sep 8, 2026 95.83 96.73 95.24 96.07 96.07 4,196,553
Sep 4, 2026 96.59 97.69 96.28 96.74 96.74 4,499,060
Sep 3, 2026 97.10 98.07 95.67 97.20 97.20 4,783,706
Sep 2, 2026 97.82 98.50 96.90 97.23 97.23 5,403,775
Sep 1, 2026 94.99 97.61 94.68 97.60 97.60 8,614,487
Aug 31, 2026 93.22 94.37 92.85 93.91 93.91 10,676,760
Aug 28, 2026 93.40 93.93 93.01 93.06 93.06 3,994,223
Aug 27, 2026 93.60 94.15 92.85 92.92 92.92 4,330,313
Aug 26, 2026 93.15 94.86 92.91 94.32 94.32 6,162,107
Aug 25, 2026 94.11 94.11 92.71 92.90 92.90 4,102,481
Aug 24, 2026 93.15 94.19 92.54 94.11 94.11 9,231,692
Aug 21, 2026 94.00 94.39 92.35 93.02 93.02 5,592,453
Aug 20, 2026 93.23 94.26 93.21 93.65 93.65 6,439,680
Aug 19, 2026 95.41 95.91 93.26 93.65 93.65 6,351,620
Aug 18, 2026 94.37 95.25 93.89 94.91 94.91 6,855,122
Aug 17, 2026 96.29 96.50 93.74 94.01 94.01 7,298,832
Aug 14, 2026 94.60 97.51 94.41 97.16 97.16 9,439,256
Aug 13, 2026 95.44 96.12 94.48 94.99 94.99 6,493,249
Aug 12, 2026 93.75 95.15 93.15 94.72 94.72 8,257,543
Aug 11, 2026 95.47 96.36 93.01 93.50 93.50 8,122,813
Aug 10, 2026 95.33 96.34 94.68 95.67 95.67 7,025,233
Aug 7, 2026 95.20 96.28 94.57 95.70 95.70 12,403,394
Aug 6, 2026 100.98 101.00 96.10 96.22 96.22 10,583,035
Aug 5, 2026 93.72 100.55 93.50 99.12 99.12 18,514,644
Aug 4, 2026 105.00 105.00 103.27 104.42 104.42 7,229,227
Aug 3, 2026 105.36 105.69 104.25 105.37 105.37 5,377,252
Jul 31, 2026 105.49 105.77 104.31 104.43 104.43 7,081,286
Jul 30, 2026 105.00 105.48 103.01 105.22 105.22 7,738,249
Jul 29, 2026 110.00 110.00 105.84 105.92 105.92 7,718,243
Jul 28, 2026 107.97 109.59 107.08 109.34 109.34 6,682,269
Jul 27, 2026 107.41 107.88 105.36 107.07 107.07 7,857,618
Jul 24, 2026 107.65 108.39 106.91 107.74 107.74 5,370,540
Jul 23, 2026$0.665 dividend 107.27 107.55 106.00 106.89 106.89 5,823,895
Jul 22, 2026 110.23 110.68 107.87 108.08 107.41 9,536,251
Jul 21, 2026 107.84 110.62 107.30 110.60 109.92 9,856,298
Jul 20, 2026 107.31 108.90 107.13 107.61 106.94 6,628,846
Jul 17, 2026 107.36 108.97 106.61 107.47 106.81 6,608,659
Jul 16, 2026 108.12 108.67 105.68 106.50 105.84 12,025,143
Jul 15, 2026 105.54 107.94 103.56 105.91 105.25 6,939,634
Jul 14, 2026 106.59 106.93 105.10 106.18 105.52 11,396,143
Jul 13, 2026 105.00 106.39 104.62 105.90 105.25 7,264,352
Jul 10, 2026 103.69 105.46 102.40 104.15 103.51 9,356,258
Jul 9, 2026 104.77 105.15 102.34 102.81 102.17 8,474,175
Jul 8, 2026 104.32 105.69 103.75 104.47 103.82 4,766,555
Jul 7, 2026 103.65 104.52 102.40 104.33 103.69 4,967,277
Jul 6, 2026 105.09 105.38 101.78 102.08 101.45 5,709,882
Jul 2, 2026 104.58 105.23 103.22 104.72 104.07 5,522,758
Jul 1, 2026 103.41 104.87 102.75 104.81 104.16 7,508,400
Jun 30, 2026 104.07 104.67 102.69 103.45 102.81 5,623,498
Jun 29, 2026 103.80 104.33 103.04 103.58 102.94 4,788,389
Jun 26, 2026 104.86 106.15 103.55 104.34 103.69 9,690,891
Jun 25, 2026 102.28 104.94 102.28 104.66 104.01 8,920,355
Jun 24, 2026 101.87 102.41 99.81 101.87 101.24 8,491,224
Jun 23, 2026 101.56 102.05 100.78 101.57 100.94 6,435,317
Jun 22, 2026 99.79 103.12 99.00 101.30 100.67 9,810,553
Jun 18, 2026 99.16 99.22 97.84 98.32 97.71 21,578,828
Jun 17, 2026 100.31 100.77 98.56 99.16 98.55 6,078,259
Jun 16, 2026 100.72 101.00 98.75 100.72 100.10 5,058,168
Jun 15, 2026 100.86 101.38 98.87 100.68 100.06 7,417,116
Jun 12, 2026 100.89 102.77 100.01 101.96 101.33 11,178,446
Jun 11, 2026 98.24 100.55 97.10 100.48 99.86 14,115,924
Jun 10, 2026 97.76 98.61 96.13 98.02 97.41 8,732,714
Jun 9, 2026 96.70 97.52 95.92 97.06 96.46 6,175,991
Jun 8, 2026 95.95 97.27 94.89 97.08 96.48 6,082,306
Jun 5, 2026 94.97 96.63 94.97 95.93 95.34 9,704,795
Jun 4, 2026 93.55 94.87 93.00 94.82 94.23 12,339,777
Jun 3, 2026 90.05 93.32 90.00 91.37 90.81 7,581,483
Jun 2, 2026 90.55 91.19 89.42 89.50 88.95 5,652,045
Jun 1, 2026 91.13 91.85 90.19 90.62 90.06 5,153,847
May 29, 2026 92.67 93.58 90.57 90.98 90.42 9,729,968
May 28, 2026 92.21 94.17 91.97 92.97 92.39 6,901,906
May 27, 2026 90.99 92.09 90.65 92.07 91.50 5,403,371
May 26, 2026 93.06 93.51 90.71 90.73 90.17 5,624,429
May 22, 2026 93.29 94.15 93.00 93.26 92.68 4,838,610
May 21, 2026 93.16 93.93 92.56 93.32 92.74 6,479,005
May 20, 2026 95.18 96.37 93.00 93.28 92.70 7,886,210
May 19, 2026 95.21 95.46 93.92 94.18 93.60 12,935,774
May 18, 2026 95.70 96.45 94.88 95.99 95.40 7,208,687
May 15, 2026 97.50 97.87 95.84 95.89 95.30 8,798,380
May 14, 2026 98.32 98.43 96.58 97.15 96.55 9,299,641
May 13, 2026 95.50 98.22 94.30 98.11 97.50 12,552,652
May 12, 2026 92.22 95.36 91.50 95.15 94.56 12,802,558
May 11, 2026 91.16 92.77 90.63 92.22 91.65 12,024,381
May 8, 2026 88.00 90.89 87.36 90.55 89.99 11,162,662
May 7, 2026 87.00 87.99 86.22 87.36 86.82 9,388,716
May 6, 2026 85.51 88.63 85.12 86.86 86.32 15,185,203
May 5, 2026 82.06 82.30 80.40 80.69 80.19 7,304,698
May 4, 2026 82.30 83.02 81.68 82.01 81.50 5,375,694
May 1, 2026 83.45 83.74 82.07 82.09 81.58 4,941,894
Apr 30, 2026 83.83 83.85 82.33 83.29 82.78 8,332,098
Apr 29, 2026 81.22 83.93 81.00 83.90 83.38 7,609,601
Apr 28, 2026 79.18 81.37 79.04 80.98 80.48 8,306,951
Apr 27, 2026 77.86 78.67 77.61 78.36 77.88 5,735,071
Apr 24, 2026 78.88 79.04 77.46 77.94 77.46 7,374,346
Apr 23, 2026$0.665 dividend 76.10 79.64 76.10 78.86 78.37 9,017,513
Apr 22, 2026 77.90 78.30 76.31 76.43 75.32 5,147,971
Apr 21, 2026 78.99 79.05 76.60 77.36 76.24 7,442,527
Apr 20, 2026 77.00 77.31 76.29 76.58 75.47 7,439,691
Apr 17, 2026 76.69 77.79 76.24 77.30 76.18 8,683,663
Apr 16, 2026 74.90 76.81 74.78 76.79 75.68 10,594,716
Apr 15, 2026 77.15 77.44 74.87 74.99 73.90 8,660,949
Apr 14, 2026 77.90 78.98 77.56 77.62 76.50 6,105,015
Apr 13, 2026 78.14 78.82 77.53 78.09 76.96 6,714,745
Apr 10, 2026 78.98 79.46 78.44 79.33 78.18 6,857,835
Apr 9, 2026 78.76 79.56 78.31 78.84 77.70 5,161,137
Apr 8, 2026 78.64 78.86 77.72 78.79 77.65 6,758,554
Apr 7, 2026 77.42 78.59 75.44 78.22 77.09 16,422,464
Apr 6, 2026 73.49 73.75 72.10 73.28 72.22 4,948,700
Apr 2, 2026 72.50 73.68 72.12 73.49 72.42 6,034,577
Apr 1, 2026 72.06 72.75 71.82 72.49 71.44 5,099,788
Mar 31, 2026 70.40 72.20 70.25 71.82 70.78 7,718,858
Mar 30, 2026 71.13 71.46 69.51 70.14 69.12 7,306,198
Mar 27, 2026 71.10 71.43 69.67 70.08 69.06 6,105,505
Mar 26, 2026 72.02 72.63 71.02 71.18 70.15 4,129,058
Mar 25, 2026 72.74 73.38 71.44 72.18 71.13 5,363,762
Mar 24, 2026 71.00 73.28 70.25 72.80 71.75 8,528,246
Mar 23, 2026 72.29 72.46 70.61 71.29 70.26 8,156,426
Mar 20, 2026 71.50 71.73 70.21 71.48 70.44 18,871,390
Mar 19, 2026 73.20 73.85 71.60 71.86 70.82 9,066,931
Mar 18, 2026 74.39 74.47 73.00 73.02 71.96 7,089,710
Mar 17, 2026 76.33 76.62 74.12 74.81 73.73 8,348,745
Mar 16, 2026 76.45 77.08 75.77 75.84 74.74 5,392,874
Mar 13, 2026 76.84 77.17 76.03 76.13 75.03 4,537,876
Mar 12, 2026 76.81 77.58 75.98 76.07 74.97 7,721,049
Mar 11, 2026 76.00 76.51 75.32 75.72 74.62 5,531,464
Mar 10, 2026 78.59 78.75 76.10 76.32 75.21 6,480,819
Mar 9, 2026 77.24 78.41 76.30 78.26 77.13 6,872,305
Mar 6, 2026 78.77 78.86 76.93 77.92 76.79 7,139,743
Mar 5, 2026 79.96 80.32 78.30 78.69 77.55 10,056,204
Mar 4, 2026 80.41 81.09 79.67 80.57 79.40 6,804,710
Mar 3, 2026 81.18 81.69 79.13 80.49 79.32 7,090,906
Mar 2, 2026 79.89 81.68 79.28 81.66 80.48 12,488,706
Feb 27, 2026 78.02 79.90 77.50 79.90 78.74 14,699,347
Feb 26, 2026 76.34 78.68 76.34 78.01 76.88 6,319,378
Feb 25, 2026 75.30 76.63 75.01 76.19 75.09 8,126,226
Feb 24, 2026 76.96 76.96 72.92 74.18 73.11 12,199,429
Feb 23, 2026 76.02 77.78 75.70 77.00 75.88 6,498,893
Feb 20, 2026 77.11 77.50 75.72 76.69 75.58 6,172,898
Feb 19, 2026 78.02 78.28 76.43 77.32 76.20 5,346,110
Feb 18, 2026 77.90 78.08 77.01 77.75 76.62 5,217,247
Feb 17, 2026 79.18 79.75 77.85 78.20 77.07 5,795,354
Feb 13, 2026 77.75 79.09 77.65 78.48 77.34 6,721,020
Feb 12, 2026 77.51 79.06 77.08 77.93 76.80 8,057,600
Feb 11, 2026 75.70 77.02 74.34 77.02 75.90 10,625,426
Feb 10, 2026 73.77 78.36 73.00 75.70 74.60 13,120,315
Feb 9, 2026 77.54 78.67 75.51 75.77 74.67 10,729,426
Feb 6, 2026 76.37 78.96 76.19 78.35 77.21 7,082,751
Feb 5, 2026 75.23 77.34 75.02 76.33 75.22 8,156,640
Feb 4, 2026 76.74 77.52 75.07 75.24 74.15 11,608,524
Feb 3, 2026 75.46 76.89 75.46 76.83 75.72 7,162,148
Feb 2, 2026 74.36 75.78 73.40 75.42 74.33 10,708,984
Jan 30, 2026 74.11 74.92 73.26 74.52 73.44 10,221,471
Jan 29, 2026 73.89 74.92 73.65 74.44 73.36 10,592,234
Jan 28, 2026 71.63 74.36 71.42 74.03 72.96 13,569,718
Jan 27, 2026 75.39 77.30 70.69 72.00 70.96 44,211,471
Jan 26, 2026 83.25 84.00 82.50 83.87 82.65 9,269,552
Jan 23, 2026 82.33 83.29 81.99 83.01 81.81 7,341,004
Jan 22, 2026$0.665 dividend 80.99 82.68 80.76 82.68 81.48 6,423,450
Jan 21, 2026 80.45 82.08 80.24 81.49 79.67 9,138,931
Jan 20, 2026 78.34 80.50 77.59 80.09 78.30 10,380,036
Jan 16, 2026 81.31 81.56 78.47 78.60 76.84 9,597,889
Jan 15, 2026 79.28 81.42 78.12 81.36 79.54 10,428,347
Jan 14, 2026 80.86 80.96 79.21 79.33 77.56 4,488,050
Jan 13, 2026 80.36 81.05 80.04 80.68 78.88 8,095,232
Jan 12, 2026 80.75 80.95 78.98 80.36 78.56 7,400,955
Jan 9, 2026 80.81 81.16 79.29 80.30 78.50 7,968,732
Jan 8, 2026 79.92 81.08 79.21 80.60 78.80 7,176,498
Jan 7, 2026 80.96 81.34 79.73 79.79 78.01 5,948,755
Jan 6, 2026 80.35 81.75 79.36 80.70 78.90 10,636,764
Jan 5, 2026 80.00 80.81 78.22 80.42 78.62 8,090,756
Jan 2, 2026 79.28 80.79 78.61 80.13 78.34 5,428,443
Dec 31, 2025 79.79 79.85 79.32 79.36 77.59 3,108,074
Dec 30, 2025 80.00 80.24 79.60 79.85 78.06 3,409,874
Dec 29, 2025 79.63 80.22 79.60 80.02 78.23 4,429,779
Dec 26, 2025 79.02 79.69 79.02 79.61 77.83 3,236,486
Dec 24, 2025 78.12 79.25 78.12 79.12 77.35 1,849,287
Dec 23, 2025 78.30 78.48 77.94 78.04 76.30 4,027,021
Dec 22, 2025 77.67 78.74 77.02 78.36 76.61 5,700,635
Dec 19, 2025 77.88 78.95 77.39 77.72 75.98 12,106,571
Dec 18, 2025 77.64 78.23 77.36 77.79 76.05 6,439,378
Dec 17, 2025 78.50 78.59 77.13 77.88 76.14 6,305,263
Dec 16, 2025 79.65 79.98 77.78 78.29 76.54 4,476,737
Dec 15, 2025 79.75 79.90 79.19 79.69 77.91 5,850,883
Dec 12, 2025 81.00 81.08 78.67 79.42 77.64 6,527,178
Dec 11, 2025 78.99 80.89 78.27 80.83 79.02 11,065,325
Dec 10, 2025 78.99 79.69 78.15 78.97 77.20 14,870,231
Dec 9, 2025 79.14 80.50 78.21 78.24 76.49 12,602,166
Dec 8, 2025 75.94 76.94 75.00 76.53 74.82 8,549,676
Dec 5, 2025 76.73 76.89 74.98 75.63 73.94 7,768,387
Dec 4, 2025 75.12 76.78 74.14 76.75 75.03 8,872,740
Dec 3, 2025 77.87 77.88 75.00 75.00 73.32 8,164,509
Dec 2, 2025 79.38 79.43 77.19 77.62 75.89 7,700,857
Dec 1, 2025 79.97 81.06 78.99 79.10 77.33 6,754,424
Nov 28, 2025 80.04 80.41 79.70 80.36 78.56 2,292,136
Nov 26, 2025 78.79 80.60 78.28 79.86 78.08 7,976,463
Nov 25, 2025 78.35 78.91 78.19 78.47 76.72 4,732,684
Nov 24, 2025 78.76 78.95 77.21 77.90 76.16 9,843,432
Nov 21, 2025 76.54 78.26 76.23 78.03 76.29 6,493,214
Nov 20, 2025 77.19 77.50 75.95 76.04 74.34 5,258,091
Nov 19, 2025 77.96 78.17 76.30 76.55 74.84 7,372,130
Nov 18, 2025 78.35 78.44 77.33 77.94 76.20 6,254,458
Nov 17, 2025 77.91 79.87 77.74 78.41 76.66 8,668,478
Nov 14, 2025 79.39 79.74 77.75 77.81 76.07 5,170,917
Nov 13, 2025 79.23 79.99 78.52 79.24 77.47 7,262,543
Nov 12, 2025 79.71 81.72 79.65 80.26 78.47 9,324,632
Nov 11, 2025 78.00 79.90 77.66 79.87 78.08 5,931,745
Nov 10, 2025 78.05 79.58 76.50 77.54 75.81 6,905,288
Nov 7, 2025 79.05 79.44 78.29 78.99 77.22 4,306,246
Nov 6, 2025 78.71 79.86 78.53 78.66 76.90 5,807,614
Nov 5, 2025 77.99 79.26 77.89 78.55 76.79 6,078,985
Nov 4, 2025 78.44 79.35 77.56 78.08 76.33 7,129,495
Nov 3, 2025 78.06 78.78 77.43 78.44 76.69 8,239,595
Oct 31, 2025 76.65 78.22 76.12 78.15 76.40 9,680,843
Oct 30, 2025 76.08 79.00 75.92 76.69 74.97 14,120,164
Oct 29, 2025 82.50 85.15 80.33 80.60 78.80 14,783,506
Oct 28, 2025 83.74 83.74 81.61 82.20 80.36 9,852,797
Oct 27, 2025 81.35 82.56 80.88 82.45 80.61 6,129,008
Oct 24, 2025 81.52 82.16 81.08 81.93 80.10 5,642,460
Oct 23, 2025$0.665 dividend 81.24 81.62 80.51 81.07 79.26 6,025,904
Oct 22, 2025 82.96 83.03 81.74 82.01 79.52 6,361,145
Oct 21, 2025 82.36 83.52 82.08 83.04 80.52 6,220,401
Oct 20, 2025 82.46 82.62 81.52 82.48 79.98 5,703,563
Oct 17, 2025 81.40 82.88 81.01 82.52 80.02 6,951,683
Oct 16, 2025 80.73 81.91 80.63 81.37 78.90 7,567,878
Oct 15, 2025 80.00 81.93 79.85 80.67 78.22 11,762,211
Oct 14, 2025 78.31 79.94 77.75 79.66 77.25 12,540,030
Oct 13, 2025 77.54 79.67 77.37 78.44 76.06 8,435,993
Oct 10, 2025 78.16 78.99 77.38 77.90 75.54 8,329,882
Oct 9, 2025 77.25 77.66 76.53 76.74 74.41 5,963,898
Oct 8, 2025 77.35 77.92 75.63 76.93 74.60 5,062,612
Oct 7, 2025 77.50 77.90 76.64 77.12 74.78 4,606,499
Oct 6, 2025 77.14 77.69 76.58 76.84 74.51 5,894,811
Oct 3, 2025 77.45 79.20 77.08 77.49 75.14 7,085,382
Oct 2, 2025 76.35 77.76 76.27 77.45 75.10 4,905,815
Oct 1, 2025 75.30 77.54 75.25 76.87 74.54 11,095,158
Sep 30, 2025 75.23 75.83 73.83 75.39 73.11 7,294,212
Sep 29, 2025 75.69 75.85 74.09 75.57 73.28 6,605,560
Sep 26, 2025 74.94 75.95 74.53 75.77 73.47 4,915,472
Sep 25, 2025 76.72 76.79 74.11 74.61 72.35 6,964,245
Sep 24, 2025 76.67 77.34 76.04 76.38 74.06 6,860,509
Sep 23, 2025 75.09 76.92 74.91 76.50 74.18 5,938,869
Sep 22, 2025 74.32 75.77 73.80 75.13 72.85 7,227,398

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
CVS HEALTH CORPORATION Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CVS, per a recent SEC DEF 14A filing. We estimate that the median employee at CVS HEALTH Corp is paid $63,262.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation